A5068884978- Respiratory Support and Mechanisms
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Long-Term Effects of COVID-19
- Cutaneous lymphoproliferative disorders research
- Inhalation and Respiratory Drug Delivery
- Medical Research and Treatments
- Asthma and respiratory diseases
- Intensive Care Unit Cognitive Disorders
- Total Knee Arthroplasty Outcomes
- T-cell and Retrovirus Studies
- Osteoarthritis Treatment and Mechanisms
- Orthopaedic implants and arthroplasty
China Medical University
2024
China-Japan Friendship Hospital
1999-2023
Chinese Academy of Medical Sciences & Peking Union Medical College
2022-2023
This study aimed to investigate the factors influencing decision of patients with severe knee osteoarthritis, who are covered by universal health insurance, undergo total replacement (TKR) surgery, as recommended orthopedic physicians. A questionnaire survey was used collect participants' demographics, socio-economic status, medical history, baseline Oxford Knee Score (OKS), and EuroQol-5 Dimension Questionnaire (EQ-5D). We included 704 which 487 underwent TKR (surgery group), while 217 did...
With the development of technology and medicine, mortality rate intensive care unit (ICU) has declined significantly, more professionals in medical field are also aware that disability ICU survivors remains high. More than 70% have Post-ICU Syndrome (PICS), which is mainly manifested by cognitive, physical, mental dysfunction, seriously affects quality life their caregivers. The COVID-19 pandemic brought a series problems such as shortage staff, restricted family visits, lack personalized...
Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory that seriously threatens people's health. It significantly affects the quality of life patients and presents an overwhelming economic burden on governmental perspectives, which makes COPD major public health issue in China. In this paper, we propose some methods can help to accelerate implementation Healthy China Strategy promote change attitudes towards from disease-centered health-centered. Those are composed many...
Background: For patients who experience COPD exacerbations on LAMA/LABA, GOLD recommends step-up to ICS/LAMA/LABA triple therapy for those with blood eosinophil counts (EOS) ≥ 100 cells/mm3. In the 52-week ETHOS trial (NCT02465567), BGF MDI at two ICS dose levels reduced rate of moderate/severe vs. dual therapies.
Background: In the Phase III, 52-week ETHOS study (NCT02465567), BGF MDI triple fixed-dose combination, reduced moderate/severe COPD exacerbation rate vs. dual therapies; however, rates are known to vary by season.